Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

Phase 4

Completed

• Conditions: Family Planning
• Interventions: Drug: diclofenac sodium (cataflam); Drug: hyoscine butyl bromide (buscopan)

• Registration Number: NCT02714231
• Lead Sponsor: Assiut University

Brief Summary

The aim of our study is to compare the analgesic effect of oral diclofenac sodium versus oral hyoscine butyl bromide during intrauterine device insertion.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03
• Study First Submitted: 2016-03-14
• Study First Submitted QC: 2016-03-16
• Study First Posted: 2016-03-21
• Primary Completion: 2017-02
• Study Completion: 2017-03
• Status Verified: 2017-07
• Last Update Submitted: 2017-07-15
• Last Update Posted: 2017-07-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• Women not taken analgesics or anxiolytics in the 24 hours prior insertion
• Women not taken misoprostol prior to intrauterine device insertion
• Women who will accept to participate in the study

Exclusion Criteria

• Any contraindication to intrauterine device placement

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
diclofenac	diclofenac sodium (cataflam)	oral diclofuhenac sodium
hyoscine	hyoscine butyl bromide (buscopan)	oral hyoscine butyl bromide

Primary Outcome Measures

Name	Time	Method
Mean pain score during insertion	intraoperative

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction score	5 minutes

Trial Locations

Locations (1)

Ahmed Abbas; 🇪🇬 Assiut, Cairo, Egypt